Chinese clinical guideline for continuous glucose monitoring (2012)

Chinese Medical Journal

Volumn 125, Issue 23, 2012, Pages 4167-4174

  Jia, Wei Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Clinical application; Continuous glucose monitoring; Guideline

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CHINA; CONTINUOUS INFUSION; DEVICE SAFETY; DIABETES MELLITUS; GLUCOSE SENSOR; GLYCEMIC INDEX; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTERSTITIAL FLUID; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRACTICE GUIDELINE; REFERENCE VALUE; SELF MONITORING;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; GUIDELINES AS TOPIC; HUMANS;

EID: 84870751641     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.23.002     Document Type: Article

References (73)

1. Chinese Diabetes Society. Chinese Clinical Guideline for Glucose Monitoring (2011). Chin J Diabetes Mellitus (Chin) 2011; 3: 13-21.
2. Chinese Diabetes Society. Guidelines on Continuous Glucose Monitoring Clinical Applications (2009). Natl Med J China (Chin) 2009; 89: 3388-3392.
3. Blevins TC, Bode BW, Garg SK, Grunberger G, Hirsch IB, Jovanovic L, et al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract 2010; 16: 730-745.
4. Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, et al. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96: 2968-2979.
5. Ginsberg BH. The FDA panel advises approval of the first continuous glucose sensor. Diabetes Technol Ther 1999; 1: 203-204.
6. Jia WP. Information changes recognition: clinical use of continuous glucose monitoring system. Natl Med J China (Chin) 2009; 89: 649-650.
7. Wentholt IM, Hart AA, Hoekstra JB, Devries JH. How to assess and compare the accuracy of continuous glucose monitors. Diabetes Technol Ther 2008; 10: 57-68.
8. Ran XW. The assessment of accuracy of continuous glucose monitoring. Chin J Diabetes Mellitus (Chin) 2011; 03: 196-200.
9. Lü LF, Wang C, Yang YZ, He LP, Liu GJ, Chen DW, et al. Accuracy and safety of continuous glucose monitoring system in diabetic and non-diabetic subjects. Natl Med J China (Chin) 2010; 90: 2967-2970.
10. Zhou J, Lü X, Mu Y, Wang X, Li J, Zhang X, et al. The accuracy and efficacy of real-time continuous glucose monitoring sensor in Chinese diabetes patients: a multicenter study. Diabetes Technol Ther 2012; 14: 710-718.
11. Li Q, Wang YY, Yu P, Gao P, Wu YH, Cui C, et al. Correlation of real-time continuous monitoring system with venous glucose and capillary glucose values. Natl Med J China (Chin) 2010; 90: 2971-2975.
12. Wang YY, Li Q, Yu P, Gao P, Wu YH, Cui C, et al. The accuracy of real-time continuous monitoring system at different stages and its association with glucose excursion. Chin J Endocrinol Metab (Chin) 2011; 27: 224-228.
13. Lang JM, Chen P, Wei AS, Chen FS. The fluctuating characteristics of 24 hours blood glucose in newly diagnosed patients with type 2 diabetes. Chin J Diabetes Mellitus (Chin) 2005; 13: 43-45.
14. Yu M, Zhou J, Xiang KS, Li M, Li Q, Zhou YC. Continuous glucose monitoring in newly diagnosed patients with type 2 diabetes mellitus. Chin J Diabetes Mellitus (Chin) 2005; 13: 102-104.
15. Zhou J, Jia WP, Yu M, Ma XJ, Bao YQ, Lu W. The features of postprandial glucose state in type 2 diabetes mellitus. Natl Med J China (Chin) 2006; 86: 970-975.
16. Wei AS, Wang FN, Chen P, Zhi M, Chen FS, Lang JM. Blood glucose profile within 24 h in type 2 diabetic patients treated by glargine combined with glimepiride and acarbose. Chin J Endocrinol Metab (Chin) 2006; 22: 325-326.
17. Bao YQ, Zhou J, Zhou M, Cheng YJ, Lu W, Pan XP, et al. Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes. Clin Exp Pharmacol Physiol 2010; 37: 564-568.
18. Kang Y, Lu JM, Zhang DD, Zhang BH, Mu YM. Effects of gliquidone treatment on glucose excursions and insulin secretions in newly diagnosed type 2 diabetic patients with continuous glucose monitoring system. Chin J Diabetes Mellitus (Chin) 2012; 4: 95-100.
19. Li XJ, Gao ZN, Chen LJ, Niu M, Li YH, Hou GM, et al. Evaluation of efficacy of acarbose by means of CGMS on blood glucose fluctuations during insulin therapy. Chin J Endocrinol Metab (Chin) 2012; 28: 140-143.
20. Wang XL, Lu JM. The effect of glycemic fluctuation on the prognosis of diabetes and diabetic chronic complications development. Section Endocrinol Foreign Med Sci (Chin) 2005; 25: 169-171,173.
21. Jia WP. Impairment of fluctuation of blood sugar upon the target organs. Natl Med J China (Chin) 2006; 86: 2524-2526.
22. Zhou J, Jia WP, Ma XJ, Bao YQ, Lu W, Li M, et al. Relationship between blood glucose variability and microalbuminuria in type 2 diabetic patients with well-controlled glycosylated hemoglobin. Natl Med J China (Chin) 2008; 88: 2977-2981.
23. Kang Y, Lu JM, Sun JF, Li CL, Wang XL, Zhang XQ, et al. Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance. Natl Med J China (Chin) 2009; 89: 669-672.
24. Zhou J, Li H, Yang WY, Ran XW, Li Q, Peng YD, et al. Relationship between early-phase insulin secretion and blood glucose variability in subject with normal glucose regulation. Chin J Diabetes Mellitus (Chin) 2009; 1: 89-93.
25. Chen XM, Zhang Y, Shen XP, Huang Q, Ma H, Huang YL, et al. Correlation between glucose fluctuations and carotid intima-media thickness in type 2 diabetes. Diabetes Res Clin Pract 2010; 90: 95-99.
26. Ma CM, Yin FZ, Wang R, Qin CM, Liu B, Lou DH, et al. Glycemic variability in abdominally obese men with normal glucose tolerance as assessed by continuous glucose monitoring system. Obesity (Silver Spring) 2011; 19: 1616-1622.
27. Su JB, Wang XQ, Chen JF, Wu G, Jin Y. Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose. Chin Med J 2011; 124: 144-147.
28. Wang Z, Li L, Zheng F, Jia C, Ruan Y, Li H. Correlation between the amplitude of glucose excursion and the oxidative/antioxidative system in subjects with different types of glucose regulation. Biomed Environ Sci 2011; 24: 68-73.
29. Sun J, Dou JT, Wang XL, Yang GQ, Lu ZH, Zheng H, et al. Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients. Chin Med J 2011; 124: 3641-3645.
30. Su JB, Wang XQ, Chen JF, Wu G, Jin Y, Xu F, et al. Glycemic variability in gestational diabetes mellitus and its association with beta cell function. Endocrine 2012; Epub ahead of print.
31. Zhong Y, Zhang XY, Miao Y, Zhu JH, Yan H, Wang BY, et al. The relationship between glucose excursion and cognitive function in aged type 2 diabetes patients. Biomed Environ Sci 2012; 25: 1-7.
32. Mi SH, Su G, Li Z, Yang HX, Zheng H, Tao H, et al. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes. Chin Med J 2012; 125: 38-43.
33. Wang Y, Zhang YL, Wang YP, Lei CH, Sun ZL. A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China. Diabetes Metab Res Rev 2012; 28: 357-362.
34. Wang C, Lü L, Yang Y, Chen D, Liu G, Chen L, et al. Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus. Clin Endocrinol (Oxf) 2012; 76: 810-815.
35. Zhou J, Jia WP. The significance and clinical evaluation of glycemic stability. Natl Med J China (Chin) 2006; 86: 2154-2157.
36. Li Q, Li PJ. The significance and clinical evaluation parameters of glycemic fluctuations. Chin J Pract Intern Med (Chin) 2009; 29: 876-878.
37. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644-655.
38. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
39. Zhou J, Yu M, Jia WP, Li Q, Li M, Ma XJ, et al. Application of continuous glucose monitoring system in the assessment of within-day and day-to-day blood glucose excursions in type 2 diabetic patients. Chin J Endocrinol Metab (Chin) 2006; 22: 286-288.
40. Kang Y, Lu JM, Lü ZH, Zhang XQ, Zheng H, Ma FL, et al. Correlation of oxidative stress and acute glucose fluctuations in subtypes of impaired glucose intolerance. Chin J Diabetes Mellitus (Chin) 2009; 1: 19-24.
41. Bian H, Gao X, Gao J. Relationship between glucose fluctuation and beta cell function in patients with diabetes. Natl Med J China (Chin) 2009; 89: 664-668.
42. Zheng F, Lu W, Jia C, Li H, Wang Z, Jia W. Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation. Endocrine 2010; 37: 201-208.
43. Wu GF, Mai YF, Luo W, Yu CY, Wu YH, Jiao JP. Relationship between bedtime blood glucose level and nocturnal hypoglycemia observed with continuous glucose monitoring system in type 2 diabetic patients. Chin J Endocrinol Metab (Chin) 2006; 22: 323-324.
44. Li M, Zhou J, Bao YQ, Lu W, Jia WP. Prediction of nocturnal hypoglycaemia with bedtime glucose level during continuous subcutaneous insulin infusion in type 2 diabetics. Natl Med J China (Chin) 2010; 90: 2962-2966.
45. Wang Y, Guan SP, Kang Y, Xue YM. Evaluation of nocturnal hypoglycemia in patients with type 2 diabetes via continuous glucose monitoring system. Chin J Endocrinol Metab (Chin) 2010; 26: 393-394.
46. Zhou L, Wu J, Xue YM. Characteristics of postprandial glucose fluctuation in gestational diabetes mellitus. J Pract Med (Chin) 2006; 22: 2250-2251.
47. Yuan T, Zhao WG, Fu Y, Dong YY, Tang Y. Application of continuous glucose monitoring system in the gestational patients with impaired glucose regulation. Chin J Clin Nutr (Chin) 2010; 18: 80-83.
48. Wang XL, Lu JM, Pan CY, Mu YM, Dou JT, Ba JM, et al. Evaluation of the superiority of insulin glargine as basal insulin replacement by continuous glucose monitoring system. Diabetes Res Clin Pract 2007; 76: 30-36.
49. Li Y, Liang J, Liang Y, Liu SY, Chen LH, Yang S, et al. Comparison of efficacy and safety of three regiments of transient intensive insulin therapy. Chin J Endocrinol Metab (Chin) 2008; 24: 620-622.
50. Luo L, Gao ZN, Lu LN, Zhu Z, Li XY, Niu M, et al. Efficacy and safety of insulin detemir in type 2 diabetes patients by the combined application of continuous glucose monitoring system and hyperinsulinemic-euglycemic clamp technique. Chin J Diabetes Mellitus (Chin) 2011; 3: 215-218.
51. Zeng WH, He XW, Shen J, Gu W. Continuous glucose monitoring in type 2 diabetes with gastroparesis. Chin J Intern Med (Chin) 2008; 47: 397-400.
52. Zhou J, Bao YQ, Li M, Liu F, Chen HB, Han JF, et al. Fulminant type 1 diabetes: the clinical features and treatment strategy. Chin J Diabetes Mellitus (Chin) 2009; 1: 34-38.
53. Lu W, Zhou J, Jia WP, Bao YQ, Ma XJ, Zhang F, et al. Characteristics and clinical significance of daily blood glucose profiles of glucocorticoid-related diabetes by continuous glucose monitoring system. J Shanghai Jiaotong Univ (Med Sci) (Chin) 2007; 27: 788-790.
54. Zhou J, Jia WP, Bao YQ, Lu W, Ma XJ, Yu M, et al. Characteristics and clinical significance of daily blood glucose profiles of insulinoma detected by continuous glucose monitoring system. J Shanghai Jiaotong Univ (Med Sci) (Chin) 2007; 27: 781-784.
55. Huang Z, Li Y, Tang T, Xu W, Liao Z, Yao B, et al. Hyperinsulinaemic hypoglycaemia associated with a heterozygous missense mutation of R1174W in the insulin receptor (IR) gene. Clin Endocrinol (Oxf) 2009; 71: 659-665.
56. Tao M, Zhou J, Zhu J, Lu W, Jia W. Continuous glucose monitoring reveals abnormal features of postprandial glycemic excursions in women with polycystic ovarian syndrome. Postgrad Med 2011; 123: 185-190.
57. Bian H, Yan H, Zeng M, Rao S, Yao X, Zhou J, et al. Increased liver fat content and unfavorable glucose profiles in subjects without diabetes. Diabetes Technol Ther 2011; 13: 149-155.
58. Su G, Mi S, Tao H, Li Z, Yang H, Zheng H, et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2011; 10: 19.
59. Chen LL, Li Q, Wang W, Cui C, Yu P, Bao LL, et al. Characteristics of glycometabolism in the first-degree relatives of type 2 diabetes patients assessed by continuous glucose monitoring system. Natl Med J China (Chin) 2009; 89: 655-658.
60. Xu Y, Zhou J, Yao HJ, Lu W, Xi CH, Sun YR, et al. Continuous glucose monitoring in Neurosurgery ICU. Chin J Neurosurg (Chin) 2010; 26: 543-546.
61. Fang F, Zhao YJ. Principle and accuracy assessment of continuous glucose monitors. Intern J Endocrinol Metab (Chin) 2007; 27: 169-171.
62. Wang XL, Lu JM, Pan CY. Study on preliminary performance of continuous glucose monitoring system in diabetic patients. Acad J PLA Postgrad Med Sch (Chin) 2005; 26: 63-65.
63. Huang C, Li R, Xu XJ, Wu LP, Gao JY, Wang XM, et al. Study on clinical utility of continuous glucose monitoring system. Chin J Prac Int Med (Chin) 2006; 26: 37-38.
64. Yu M, Zhou J, Xiang KS, Lu HJ, Ma XJ, Lu W. The glycemic excursions in normal glucose tolerance individuals revealed by continuous glucose monitoring system. Natl Med J China (Chin) 2004; 84: 1788-1790.
65. Zhou J, Jia WP, Yu M, Yu HY, Bao YQ, Ma XJ, et al. The reference values of glycemic parameters for continuous glucose monitoring and its clinical application. Chin J Intern Med (Chin) 2007; 46: 189-192.
66. He LP, Wang C, Zhong L, Yang YZ, Long Y, Zhang XX, et al. Glycemic Excursions in People with Normal Glucose Tolerance in Chengdu. J Sichuan Univ (Med Sci Edi) (Chin) 2009; 40: 704-707.
67. Zhou J, Li H, Ran X, Yang W, Li Q, Peng Y, et al. Reference values for continuous glucose monitoring in Chinese subjects. Diabetes Care 2009; 32: 1188-1193.
68. Zhou J, Li H, Ran X, Yang W, Li Q, Peng Y, et al. Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Med Sci Monit 2011; 17: CR9-CR13.
69. Lu W, Zhou J, Bao YQ, Lu FD, Jia WP. Analysis of the failure cause of continuous glucose monitoring system and nursing care. Chin J Nurs (Chin) 2008; 43: 561-562.
70. Zheng XP, Shao Y, Zou ZC, Liang L. Application and nursing care of continuous glucose monitoring system in type 1 diabetic children. Chin J Nurs (Chin) 2008; 43: 235-236.
71. Lu W, Zhou J, Bao YQ, Li M, Yu HY, Zhang L, et al. Nursing care of 2 children with type 1 diabetes during continuous glucose monitoring. Chin J Nurs (Chin) 2009; 44: 713-714.
72. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008; 359: 1464-1476.
73. Beck RW, Hirsch IB, Laffel L, Tamborlane WV, Bode BW, Buckingham B, et al. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009; 32: 1378-1383.